Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Eylea
Pharma
Bayer charts growth course amid Xarelto's ongoing sales descent
The company plans to keep building out blockbuster hopeful Nubeqa, popular Eyelea and newer Kerendia as its top-selling Xarelto succumbs to generics.
Zoey Becker
Aug 6, 2024 12:29pm
Regeneron touts Eylea HD launch, warns of potential approval delay
Aug 1, 2024 11:15am
Sales for Roche's Vabysmo rise again, but momentum is stalled
Jul 25, 2024 11:45am
Samsung Biologics' 37% sales surge propelled by biosimilars
Jul 24, 2024 10:56am
Roche's eye disease meds Vabysmo, Susvimo show extended efficacy
Jul 18, 2024 11:37am
FDA gives thumbs-up to Roche's Vabysmo in a prefilled syringe
Jul 8, 2024 10:35am
